(MLMAD) Made - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0010328302
Detection Systems, Measurement Instruments, Radar, Isolators, Warning Systems
Description: MLMAD Made
from yearly Income Tax Expense
MLMAD Stock Overview
| Market Cap in USD | 21m |
| Sub-Industry | Electronic Equipment & Instruments |
| IPO / Inception |
MLMAD Stock Ratings
| Growth Rating | 96.4% |
| Fundamental | 56.5% |
| Dividend Rating | 68.2% |
| Return 12m vs S&P 500 | 67.5% |
| Analyst Rating | - |
MLMAD Dividends
| Dividend Yield 12m | 4.82% |
| Yield on Cost 5y | 17.79% |
| Annual Growth 5y | 4.56% |
| Payout Consistency | 93.1% |
| Payout Ratio | 0.0% |
MLMAD Growth Ratios
| Growth Correlation 3m | 46% |
| Growth Correlation 12m | 91.9% |
| Growth Correlation 5y | 94.2% |
| CAGR 5y | 92.74% |
| CAGR/Max DD 5y | 3.50 |
| Sharpe Ratio 12m | -0.05 |
| Alpha | 116.71 |
| Beta | -0.049 |
| Volatility | 151.37% |
| Current Volume | 0.6k |
| Average Volume 20d | 0.1k |
| Stop Loss | 13.7 (-3.5%) |
| Signal | -0.17 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (415.5k TTM) > 0 and > 6% of Revenue (6% = 211.8k TTM) |
| FCFTA 0.0 (>2.0%) and ΔFCFTA 0.0pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| error: NWC/Revenue cannot be calculated (needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.0 (>3.0%) and CFO 0.0 <= Net Income 415.5k (YES >=105%, WARN >=100%) |
| Net Debt (-406.4k) to EBITDA (961.3k) ratio: -0.42 <= 3.0 (WARN <= 3.5) |
| error: Current Ratio cannot be calculated (needs Total Current Assets and Liabilities) |
| Outstanding Shares last Quarter (1.28m) change vs 12m ago -5.11% (target <= -2.0% for YES) |
| Gross Margin -140.0% (prev 78.07%; Δ -218.1pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.39% (prev 187.0%; Δ -130.6pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 18.87 (EBITDA TTM 961.3k / Interest Expense TTM 17.2k) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 56.50
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield data missing |
| 3. FCF Margin data missing |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC 25.36% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend -100.0% = -5.0 |
| 9. Rev. CAGR 0.0% = 0.0 |
| 10. EPS Trend data missing |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of MLMAD shares?
As of August 30, 2025, the stock is trading at EUR 14.20 with a total of 636 shares traded.
Over the past week, the price has changed by +8.40%, over one month by +35.24%, over three months by +20.34% and over the past year by +97.09%.
Over the past week, the price has changed by +8.40%, over one month by +35.24%, over three months by +20.34% and over the past year by +97.09%.
Is Made a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Made is currently (August 2025)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 56.50 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MLMAD is around 17.73 EUR . This means that MLMAD is currently undervalued and has a potential upside of +24.86% (Margin of Safety).
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MLMAD is around 17.73 EUR . This means that MLMAD is currently undervalued and has a potential upside of +24.86% (Margin of Safety).
Is MLMAD a buy, sell or hold?
Made has no consensus analysts rating.
What are the forecasts/targets for the MLMAD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 19.3 | 35.8% |
MLMAD Fundamental Data Overview
Market Cap USD = 20.8m (17.8m EUR * 1.1648 EUR.USD)
Market Cap EUR = 17.8m (17.8m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 406.4k EUR (Cash And Short Term Investments, last fiscal year)
P/S = 2.579
Beta = -0.332
Revenue TTM = 3.53m EUR
EBIT TTM = 325.0k EUR
EBITDA TTM = 961.3k EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -406.4k EUR (from netDebt column, last fiscal year)
Enterprise Value = 17.4m EUR (17.8m + (null Debt) - CCE 406.4k)
Interest Coverage Ratio = 18.87 (Ebit TTM 325.0k / Interest Expense TTM 17.2k)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 17.4m)
FCF Margin = unknown (0.0 / 3529620.0)
Net Margin = 11.77% (Net Income TTM 415.5k / Revenue TTM 3.53m)
Gross Margin = -140.0% ((Revenue TTM 3.53m - Cost of Revenue TTM 8.47m) / Revenue TTM)
Tobins Q-Ratio = 61.74 (Enterprise Value 17.4m / Book Value Of Equity 282.0k)
Interest Expense / Debt = unknown (Interest Expense 17.2k / Debt none)
Taxrate = 1.81% (from yearly Income Tax Expense: 20.3k / 1.12m)
NOPAT = 319.2k (EBIT 325.0k * (1 - 1.81%))
Current Ratio = unknown (Total Current Assets 5.11m / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt -406.4k / EBITDA 961.3k)
Debt / FCF = none (Debt none / FCF TTM 0.0)
RoA = 6.50% (Net Income 415.5k, Total Assets 6.39m )
RoE = unknown (Net Income TTM 415.5k / Total Stockholder Equity none)
RoCE = unknown (Ebit 325.0k / (Equity none + L.T.Debt none))
RoIC = 25.36% (Ebit 325.0k / (Assets 6.39m - Current Assets 5.11m))
WACC = unknown (E(17.8m)/V(0.0) * Re(5.83%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(0.02)))
Shares Correlation 5-Years: -94.90 | Cagr: -1.74%
Discount Rate = 5.83% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Revenue Correlation: -100.0 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: N/A
EPS Correlation: N/A | EPS CAGR: 0.0%
EPS Growth-of-Growth: N/A
Market Cap EUR = 17.8m (17.8m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 406.4k EUR (Cash And Short Term Investments, last fiscal year)
P/S = 2.579
Beta = -0.332
Revenue TTM = 3.53m EUR
EBIT TTM = 325.0k EUR
EBITDA TTM = 961.3k EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -406.4k EUR (from netDebt column, last fiscal year)
Enterprise Value = 17.4m EUR (17.8m + (null Debt) - CCE 406.4k)
Interest Coverage Ratio = 18.87 (Ebit TTM 325.0k / Interest Expense TTM 17.2k)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 17.4m)
FCF Margin = unknown (0.0 / 3529620.0)
Net Margin = 11.77% (Net Income TTM 415.5k / Revenue TTM 3.53m)
Gross Margin = -140.0% ((Revenue TTM 3.53m - Cost of Revenue TTM 8.47m) / Revenue TTM)
Tobins Q-Ratio = 61.74 (Enterprise Value 17.4m / Book Value Of Equity 282.0k)
Interest Expense / Debt = unknown (Interest Expense 17.2k / Debt none)
Taxrate = 1.81% (from yearly Income Tax Expense: 20.3k / 1.12m)
NOPAT = 319.2k (EBIT 325.0k * (1 - 1.81%))
Current Ratio = unknown (Total Current Assets 5.11m / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt -406.4k / EBITDA 961.3k)
Debt / FCF = none (Debt none / FCF TTM 0.0)
RoA = 6.50% (Net Income 415.5k, Total Assets 6.39m )
RoE = unknown (Net Income TTM 415.5k / Total Stockholder Equity none)
RoCE = unknown (Ebit 325.0k / (Equity none + L.T.Debt none))
RoIC = 25.36% (Ebit 325.0k / (Assets 6.39m - Current Assets 5.11m))
WACC = unknown (E(17.8m)/V(0.0) * Re(5.83%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(0.02)))
Shares Correlation 5-Years: -94.90 | Cagr: -1.74%
Discount Rate = 5.83% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Revenue Correlation: -100.0 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: N/A
EPS Correlation: N/A | EPS CAGR: 0.0%
EPS Growth-of-Growth: N/A